tirzepatide shortage news october 2025 Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the Navigating the Post-Shortage Era |

Dosing Considerations The goal is to use the lowest effective dose that adequately controls your symptoms

5.18.26 Christine said: Ok for nursing but not pregnancy due to licorice root 5.17.26 Sofia said: Hi and thank you for all of your guidance

Mixed-effects regression analyses incorporating therapy duration and time since cessation as predictors of weight change were also performed

This drug is specifically designed to assist adults with a BMI of 30 or higher, or 27 with an additional weight-related health condition

Without direct tissue quantification, it is unknown if the CNS exposure was high, or if the large systemic dose simply compensated for low anatomical delivery efficiency across the nasal mucosa